Bilcare Acquires Clinical Trial Services Co.

Bilcare has acquired DHP Ltd., a clinical trials service provider based in Powys, UK. DHP specializes in the manufacture, import, storage and distribution of Phase I-IV investigational medicinal products for the pharma, biopharma and CRO industries. This includes a full range of Qualified Person (QP) services to support product lifecycles, from design through reconciliation and destruction. DHP also provides GMP/GCP compliant services and works in accordance with the EU Clinical Trials Directive.

Mohan Bhandari, chairman and managing director of Bilcare, commented, “Bilcare has been successful in living up to its commitment of providing a truly worldwide operating network to the global pharmaceutical sector and partnering with them to enhance their speed-to-market by best in class local management of global clinical trials.”

Steven A. Jacobs, president of Bilcare added, “This acquisition gives us the ability to fulfill global customers’ needs, providing quality support that enables them to manufacture, package, test, store and distribute clinical supplies in the EU. It also provides DHP with the ability to do the same in the U.S. and India, while adding a full range of analytical and Interactive Voice Response System (IVRS) capabilities to their clinical supply chain. The greatest achievement from this venture is the perfect alignment of quality systems, people, processes and values that both companies hold in high regard. Working together will be a seamless collaboration which is what customers are looking for in the clinical supplies and services industry.”